Lee Tien-Li — SEC Form 4 filings
SEC reporting owner CIK 1940120. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-11.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2025-02-19 to 2026-02-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 4 filings — 53,542 shares, $623,345 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 16,542 shares @ $16.00 ($264,672) in Aardvark Therapeutics, Inc., filed 2025-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer, Director, 10% owner | 8 | 7 legs · 53,542 sh · $623,345 | — | 8 |
Form 4 filings — Lee Tien-Li
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-11 | 4 | Aardvark Therapeutics, Inc. (AARD) | Grant/award (A): 203,851 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | Aardvark Therapeutics, Inc. (AARD) | Purchase (P): 7,000 @ $14.48 | EDGAR |
| 2025-10-16 | 4 | Aardvark Therapeutics, Inc. (AARD) | Option exercise (M): 1,229 @ $4.24 · Option exercise (M): 1,229 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | Aardvark Therapeutics, Inc. (AARD) | Purchase (P): 6,500 @ $9.51 · Purchase (P): 3,500 @ $9.94 | EDGAR |
| 2025-09-12 | 4 | Aardvark Therapeutics, Inc. (AARD) | Purchase (P): 9,000 @ $7.91 · Purchase (P): 6,000 @ $7.82 · Purchase (P): 5,000 @ $8.50 | EDGAR |
| 2025-08-29 | 4 | Aardvark Therapeutics, Inc. (AARD) | Option exercise (M): 17,209 @ $4.24 · Option exercise (M): 17,209 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Aardvark Therapeutics, Inc. (AARD) | Grant/award (A): 549,534 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Aardvark Therapeutics, Inc. (AARD) | Conversion (C): 41,303 · Purchase (P): 16,542 @ $16 · Conversion (C): 350,002 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1940120 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →